First Wave BioPharma Statistics
Total Valuation
FWBI has a market cap or net worth of $6.32 million. The enterprise value is $3.40 million.
Market Cap | 6.32M |
Enterprise Value | 3.40M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
FWBI has 2.03 million shares outstanding. The number of shares has increased by 836.57% in one year.
Shares Outstanding | 2.03M |
Shares Change (YoY) | +836.57% |
Shares Change (QoQ) | -11.09% |
Owned by Insiders (%) | 7.69% |
Owned by Institutions (%) | 4.07% |
Float | 1.91M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.75 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.58 |
Quick Ratio | n/a |
Debt / Equity | 0.23 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -702.16 |
Financial Efficiency
Return on equity (ROE) is -614.80% and return on invested capital (ROIC) is -356.02%.
Return on Equity (ROE) | -614.80% |
Return on Assets (ROA) | -284.10% |
Return on Capital (ROIC) | -356.02% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.79M |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.38% in the last 52 weeks. The beta is 1.21, so FWBI's price volatility has been higher than the market average.
Beta (1Y) | 1.21 |
52-Week Price Change | -94.38% |
50-Day Moving Average | 4.95 |
200-Day Moving Average | 6.64 |
Relative Strength Index (RSI) | 37.56 |
Average Volume (30 Days) | 114,977 |
Short Selling Information
The latest short interest is 55,041, so 2.72% of the outstanding shares have been sold short.
Short Interest | 55,041 |
Short Previous Month | 13,849 |
Short % of Shares Out | 2.72% |
Short % of Float | 2.88% |
Short Ratio (days to cover) | 0.38 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.77M |
Pretax Income | -15.79M |
Net Income | -16.10M |
EBITDA | -15.74M |
EBIT | -15.77M |
Earnings Per Share (EPS) | -$47.88 |
Balance Sheet
The company has $3.74 million in cash and $826,844 in debt, giving a net cash position of $2.92 million or $1.44 per share.
Cash & Cash Equivalents | 3.74M |
Total Debt | 826,844 |
Net Cash | 2.92M |
Net Cash Per Share | $1.44 |
Equity / Book Value | 3.60M |
Book Value Per Share | 1.78 |
Working Capital | 1.82M |
Cash Flow
Operating Cash Flow | -12.38M |
Capital Expenditures | n/a |
Free Cash Flow | -12.38M |
FCF Per Share | -$36.80 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FWBI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -836.57% |
Shareholder Yield | -836.57% |
Earnings Yield | -254.85% |
FCF Yield | -195.89% |
Analyst Forecast
The average price target for FWBI is $36.00, which is 1,053.85% higher than the current price. The consensus rating is "Buy".
Price Target | $36.00 |
Price Target Difference | 1,053.85% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 18, 2023. It was a reverse split with a ratio of 1:20.
Last Split Date | Dec 18, 2023 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |